Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies. Bempedoic acid(ETC1002) is absorbed rapidly in the small intestine and enters the liver through cell surface receptors different from those transporters that selectively take up statins. Bempedoic acid(ETC1002) is a regulator of lipid and carbohydrate metabolism.
Molecular Weight:
344.49
Purity:
99.84%
CAS Number:
[738606-46-7]
Formula:
C19H36O5
Target:
ATP Citrate Lyase|||AMPK
T3625
* VAT and and shipping costs not included. Errors and price changes excepted